Pleurisy Market - Key Players, Trends, Share, Industry Size, Growth, Opportunities, And Forecast (2025 - 2032)

Pleurisy Market Overview

Pleurisy is a condition in which the pleura — two large, thin layers of tissue that separate the lungs from our chest wall — becomes inflamed.  It is also called  as pleuritis, pleurisy causes sharp chest pain called as pleuritic pain that worsens during breathing. The common symptoms are chest pain, breathing problem, cough and fever. It is usually caused due to Viral infection, Bacterial infection, Fungal infection, Pulmonary embolism and Tuberculosis (TB).

The global pleurisy market is increasing due to rise of respiratory disease that is pneumonia, TB and lung cancer as this diseases cause inflammation and further it can cause pleurisy therefore the demand of effective diagnosis and treatment has increased. The advanced and new diagnostic technology like CT scans, MRI and ultrasound help us to identify and give accuracy in Pleurisy diagnosis so that we can make the patient outcome better.

North America leads in terms of pleurisy treatment as there is high incidence of respiratory disease which influenced the country to make well-established healthcare infrastructure for the betterment of people. Europe is also getting benefits from their government regulation and scheme and Asia pacific is experiencing fast growth due to awareness among people related to disease and all the information regarding it.

Many companies are investing in Research and innovation which is helping in more efficient and effective invention for  pleurisy basically they are focusing on AI -driven diagnostics and  personalized medicines is changing diagnosis of pleurisy which is ultimately reducing the hospital stay and improving patient outcomes. As advancement and innovation continue to grow the market is seeing steady growth and new opportunities in healthcare and pharmaceutical products.

To get more Insights: Request Free Sample Report

Global Pleurisy Market Dynamics

The  pleurisy market is driven by new invention in diagnostic technology  and it is helping in pleurisy the imaging techniques is one of the best way to find pleurisy in any person and it  help them to get diagnosed with it. The imaging technique are CT scans, MRI and ultra sound They provide a high resolution image of the pleural cavity, helping in correct diagnostic treatment and timely action for pleurisy. There are many other respiratory condition also which can create problems in understanding the symptoms so this techniques is helping to identify the difference between pleurisy and other respiratory condition therefore there is a high demand of machines that identifies  pleurisy that   also help in determining and treatment of it.

Lack of awareness and misdiagnosis can be a major problem in pleurisy  market as  many people are not aware of the symptoms of pleurisy so many a times they get confused with the symptoms of pleurisy and other respiratory problem that can be pneumonia, TB or lung cancer so to get resolved of this problem  companies like Sonde Health and Koye Pharmaceutical are Investing in research & development to improve pleurisy diagnostic kits and biomarkers their technology help to analyzes voice samples to monitor respiratory health and potentially aiding in the early detection of various other respiratory conditions as well.

There is a big opportunity in Integration of AI and Telemedicine as  AI is developing rapidly and the way people are adapting or using AI there can be a big chance for AI-based diagnosis and treatment which help patients in diagnosis and also in remote patient monitoring  it is  improve accessibility to treatment in remote areas. It is also reducing the chances of infection as pleurisy is a spreadable disease and  the person who is in contact with him/her can also get infected  so therefore remote patient monitoring  is helping with it.

Global Pleurisy Market segment analysis

On the basis of Type, Global Pleurisy Market  is segmented into Dry Pleurisy, Wet Pleurisy, Purulent Pleurisy and Haemorrhagic Pleurisy. In this segmentation wet pleurisy dominated the market in 2024 and it is expected to hold the largest Pleurisy market share over the forecast period also as it has high prevalence rate there is also a high increase in hospitalization rate that is increases higher market demand for treatment.

On  the basis of Diagnosis method, Global Pleurisy Market is segmented into Imaging Test, Blood Test, Thoracentesis and Biopsy. In this  the imaging test segment dominated the market in 2024 and it is expected to hold the largest share in future as well due to its high usage in initial diagnosis and  it is non-Invasive and widely available in market whereas blood test can hold the second position followed by thoracentesis and biopsy.

On the basis of treatment, Global Pleurisy Market  is segmented into Medication Based Treatment, Surgical and Procedural Treatment. Whereas the medication based treatment includes NSAIDs, antibiotics, corticosteroids and antiviral and the surgical and procedural treatment includes Thoracentesis, pleurodesis and surgery which help in treatment of pleurisy.

On the basis of End-user, Global Pleurisy Market is segmented into Hospital And Clinics, Ambulatory Surgical Centre, Diagnostic Centres and  Homecare Setting whereas the hospital and clinics is  are the largest segments due to high patients admission and surgery. The diagnostic centre is used  primarily for  imaging and lab testing the homecare setting is for patients on long term medication or oxygen therapies.

Global Pleurisy Market Regional Insights

The global pleurisy market differ across many regions based on healthcare support, disease prevalence, and economic conditions. North America leads the Pleurisy Market as it has advanced medical technologies, well-developed healthcare system, and high prevalence of respiratory conditions as well. The United States and Canada have extensive research initiatives and early detection program which gives better diagnosis and treatment out. The Insurance coverage and government support for respiratory disease treatment has also contribute to market growth in US and Canada .

Europe is next leading pleurisy market with major countries like Germany, the UK, and France giving profit from strong healthcare systems and a focus on respiratory health. The region has well-established diagnostic capabilities and access to innovative treatments that has driven the demand for imaging technologies and medications. Increasing awareness and preventive care in pleurisy has initiated further  which enhance early diagnosis and intervention which is making Europe a major player in the pleurisy market. Asia-Pacific is  also experiencing the fastest growth, driven by high industrialization, rising pollution levels and lung infections. Countries like China, India, and Japan are investing in healthcare infrastructure and expanding its access to diagnostic and treatment facilities.

Global Pleurisy Market Competitive Landscape

The global pleurisy market is rising at high competition, and there are many key players that are contributing to new technologies in terms of diagnosis and treatment for pleurisy. There are many Leading companies such as Scanlan International, Sontec Instruments, Pilling Surgical, Integra Life Sciences, and Olympus Corporation they has specialized in developing innovative medical devices, surgical instruments, and imaging technologies that is helping in pleurisy. These companies is fully focused on increasing patient outcomes through accurate tools and cutting-edge medical technologies that gives effective management for pleurisy.

The AstraZeneca and Pfizer have developed vaccines targeting pneumonia as it often result from infection like pneumonia. The pneumonia- causing pathogens, thereby  indirectly influencing pleurisy prevention AstraZeneca  has developed suvrotoxumab and Pfizer has invented Prevnar 13  both companies effort in pneumonia prevention has contribute to reducing pleurisy incidence

Market growth is driven by many factors such as the high prevalence of respiratory diseases, technological advancements in healthcare, and rising healthcare expenditure worldwide. Companies are highly involved in research initiatives, strategic collaborations, and product development to improve treatment options and to expand their global footprint. As the demand for effective pleurisy management solutions continues to increase, competition among key players is expected to rise a lot, leading to further innovations in the market.

Key Players In Global Pleurisy Market

1. Pfizer Inc. – New York City, United States
2. GlaxoSmithKline plc (GSK) – Brentford, United Kingdom
3. Novartis International AG – Basel, Switzerland
4. Sanofi S.A. – Paris, France
5. AstraZeneca plc – Cambridge, United Kingdom
6. Merck & Co., Inc. – Kenilworth, United States
7. Johnson & Johnson – New Brunswick, United States
8. Roche Holding AG – Basel, Switzerland
9. Bayer AG – Leverkusen, Germany
10. Boehringer Ingelheim GmbH – Ingelheim am Rhein, Germany
11. Eli Lilly and Company – Indianapolis, United States
12. AbbVie Inc. – North Chicago, United States
13. Gilead Sciences, Inc. – Foster City, United States
14. Bristol Myers Squibb Company – New York City, United States
15. Takeda Pharmaceutical Company Limited – Tokyo, Japan
16. Cipla Limited – Mumbai, India
17. Teva Pharmaceutical Industries Ltd. – Petah Tikva, Israel
18. Mylan N.V. – Canonsburg, United States
19. Sun Pharmaceutical Industries Ltd. – Mumbai, India
20. Dr. Reddy's Laboratories Ltd. – Hyderabad, India
21. Amgen Inc. – Thousand Oaks, United States
22. Biogen Inc. – Cambridge, United States
23. Vertex Pharmaceuticals Incorporated – Boston, United States
24. Regeneron Pharmaceuticals, Inc. – Tarrytown, United States
25. Allergan plc – Dublin, Ireland
26. Sandoz International GmbH – Holzkirchen, Germany
27. Hikma Pharmaceuticals plc – London, United Kingdom
28. Zydus Cadila – Ahmedabad, India
29. Lupin Limited – Mumbai, India
30. Aurobindo Pharma Limited – Hyderabad, India